Status:

COMPLETED

A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression

Lead Sponsor:

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions:

Bipolar Disorder

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This is a 6-week trial that evaluates the efficacy and safety of Geodon (ziprasidone) in outpatient subjects ages 18 and older with Bipolar Disorder type I, depressed. Subjects are required to undergo...

Eligibility Criteria

Inclusion

  • Subjects must have a primary diagnosis of Bipolar I Disorder, most recent episode depressed, with or without rapid cycling, without psychotic features, as defined in Diagnostic and Statistical Manual (of Mental Disorders) - Fourth Edition - Text Revision (DSM-IV-TR) (296.5X) and confirmed by a structured Mini International Neuropsychiatric Interview (MINI)

Exclusion

  • Subjects with a DSM-IV TR diagnosis of schizophrenia (295.XX), schizoaffective disorder (295.70), schizophreniform disorder (295.40), delusional disorder (297.1), or psychotic disorder not otherwise specified (298.9).
  • Subjects with other DSM-IV TR Axis I or Axis II disorder (in addition to Bipolar I disorder) are ineligible if the comorbid condition is clinically unstable, requires treatment, or has been a primary focus of treatment within the 6 month period prior to screening.

Key Trial Info

Start Date :

July 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2008

Estimated Enrollment :

536 Patients enrolled

Trial Details

Trial ID

NCT00141271

Start Date

July 1 2005

End Date

February 1 2008

Last Update

March 25 2021

Active Locations (72)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 18 (72 locations)

1

Pfizer Investigational Site

Birmingham, Alabama, United States, 35209

2

Pfizer Investigational Site

Dana Point, California, United States, 92629

3

Pfizer Investigational Site

La Mesa, California, United States, 91942

4

Pfizer Investigational Site

Laguna Hills, California, United States, 92653